Table of Content




1. Executive Summary


2. Global Alzheimer’s Disease Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Alzheimer’s Disease Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Alzheimer’s Disease Diagnostic Market by Type
3.3.1: Nervous System
3.3.2: Examination
3.3.3: Genetic Testing
3.3.4: Minor Mental State Examination
3.3.5: Brain Imaging Tests

3.4: Global Alzheimer’s Disease Diagnostic Market by End Use
3.4.1: Clinics
3.4.2: Hospitals
3.4.3: Diagnostic Centers
3.4.4: Pharmaceutical Companies
3.4.5: Academic Research Centers






4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Alzheimer’s Disease Diagnostic Market by Region
4.2: North American Alzheimer’s Disease Diagnostic Market
4.2.2: North American Alzheimer’s Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers


4.3: European Alzheimer’s Disease Diagnostic Market
4.3.1: European Alzheimer’s Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.3.2: European Alzheimer’s Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers


4.4: APAC Alzheimer’s Disease Diagnostic Market
4.4.1: APAC Alzheimer’s Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.4.2: APAC Alzheimer’s Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers


4.5: ROW Alzheimer’s Disease Diagnostic Market
4.5.1: ROW Alzheimer’s Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.5.2: ROW Alzheimer’s Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Alzheimer’s Disease Diagnostic Market by Type
6.1.2: Growth Opportunities for the Global Alzheimer’s Disease Diagnostic Market by End Use

6.1.3: Growth Opportunities for the Global Alzheimer’s Disease Diagnostic Market by Region

6.2: Emerging Trends in the Global Alzheimer’s Disease Diagnostic Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Alzheimer’s Disease Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Alzheimer’s Disease Diagnostic Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: AbbVie
7.2: AC Immune
7.3: AMARANTUS BIOSCIENCE
7.4: Anavex Life Sciences
7.5: Eli Lilly and Company
7.6: AXON Neuroscience
7.7: Sio Gene Therapies